| Pharmaceutical active ingredients: |
| Mitoxantrone Hydrochloride |
| Available forms, composition and doses of Mitoxantrone: |
| Injectable; Injection; Mitoxantrone Hydrochloride 2 mg / ml |
| Mitoxantrone medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DB07 - Mitoxantrone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Ebewe |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mitoxan | Mitoxantrone Hydrochloride | ADiPharm |
| Mitoxantron | Mitoxantrone Hydrochloride | Ebewe; Firma Vai Hong; Sandoz; Zuellig Pharma |
| Mitoxantrona | Mitoxantrone Hydrochloride | Baxter |
| Mitoxantrone | Mitoxantrone Hydrochloride | APP Pharmaceuticals |
| Mitoxantrone | Mitoxantrone Hydrochloride | Baxter |
| Mitoxantrone | Mitoxantrone Hydrochloride | Fresenius |
| Mitoxantrone | Mitoxantrone Hydrochloride | Generamedix |
| Mitoxantrone | Mitoxantrone Hydrochloride | Hospira |
| Mitoxantrone | Mitoxantrone Hydrochloride | Jelfa Pharmaceuticals Works |
| Mitoxantrone | Mitoxantrone Hydrochloride | Mayne Pharma |